[Granulomatous hepatitis due to Mycobacterium complex following Bacillus Calmette-Guérin intravesical instillation].
Villamil-Cajoto
Iago
I
Jove
Maria Jesús
MJ
Serrano
Marta
M
Pousa
Montserrat
M
D000283:Administration, Intravesical; D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000601:surgery / Q000628:therapy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D002761:Cholangitis / Q000209:etiology; D002763:Cholecystectomy; D002764:Cholecystitis / Q000209:etiology / Q000601:surgery; D003131:Combined Modality Therapy; D015653:Cystectomy / Q000379:methods; D003937:Diagnosis, Differential; D006099:Granuloma / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D008954:Models, Biological; D009163:Mycobacterium bovis / Q000276:immunology / Q000302:isolation & purification; D011183:Postoperative Complications / Q000209:etiology / Q000382:microbiology; D014386:Tuberculosis, Hepatic / Q000175:diagnosis / Q000209:etiology* / Q000382:microbiology; D001749:Urinary Bladder Neoplasms / Q000601:surgery / Q000628:therapy
D000995:Antitubercular Agents; D001500:BCG Vaccine